Skip to main content
. 2019 Jan 11;10(4):480–493. doi: 10.18632/oncotarget.26558

Figure 6. Synergistic effect of AZD4547 and cisplatin on LGACC cell migration and proliferation.

Figure 6

(A) Representative images of migration assay results for LGACC cells after 48 hrs. of control, cisplatin, AZD4547, or combinatorial treatment. (B) Quantitative analysis of gap bridging percentage in migration assay of LGACC cells under different treatments. (C) Growth curve analysis of LGACC cells over 7 days of control, cisplatin, AZD4547, or combinatorial treatment. Data presented as mean±SD (*p<0.05; **p<0.01; ***p<0.001 compared with control; #p<0.01 wrt to cisplatin; +p<0.01 wrt to AZD4547).